Replies to post #3002 on Navidea Biopharmaceuticals Inc (NAVB)

[sts66]

Doubtful....they would have made it a Class 1 resub if they had wanted to.....although I certainly HOPE they spring a surprise on the ^$%* shorts! NAVB is going to have to tap their line of credit to make it another 6 months without revs, I'm afraid...